Nucleosyn
  • Home
  • Products
    • All products
    • Products categories
    • DNA-RNA
    • Synthetic lipids
    • Stable isotope
    • Custom chemical synthesis
  • Capabilities
  • About Us
  • Contact
  • Linkedin

My selection

Synthetic lipids

NucleoSyn produces and supplies synthetic lipids from milligrams to multi-kilos quantities.

PEG 2000 PE (18:0)

CAS #
474922-77-5
Packing size
100 mg, 500 mg, 1 g, bulk (gram scale)
Synonyme(s)
DSPE-mPEG(2000)
PhospholipidPegylatedNanoparticleLNPLiposomeTransfectionLipid
PEG 2000 PE (18:0) Image 1

PEG 2000 PE (18:0) is used in combination with other phospholipids for drug delivery. PEG 2000 PE (18:0) is known to prevent the uptake of drugs by the mononuclear phagocyte system and is a potential drug carrier for cancer therapy.

Aspect
White powder
Purity
98%
Solubility
EtOH, DMF, DMSO
Molecular weight
(average) 2805.49
Molecular formula

(average) C133H267N2O55P 

IUPAC
(R)-2,3-bis(stearoyloxy)propyl (138-oxo-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68, 71,74,77,80,83,86,89,92,95,98,101,104,107,110,113,116,119,122,125,128,131,134,137-hexatetracontaoxa-139-azahentetracontahectan-141-yl) phosphate

A. Cooper, et al., Langmuir, 2023, 39, 5579-5590. read article

Z. Huang, et al., RSC Adv., 2023, 13, 1617-1626. read article

Purchase PEG 2000 PE (18:0)

Get a quote on this product

We're ready to solve any rare chemicals sourcing or molecular design problem... Give us a shout! Please fill out this form completely.

If you don't find a product in our current offer, please don't hesitate to request a quote using our contact form.

Add to my selection

Related products

[13C6]-Glucosylsphingosine ([13C6]-GlSph...
CAS #
299172-48-8
Details
[D5]-Phosphatidylethanol / [d5] - PEth a...
CAS #
1612140-92-7
Details
Glucosylsphingosine / (GlSph)
CAS #
52050-17-6
Details
See more products

logo footerNucleosyn

111 Bd Duhamel du Monceau

45160 Olivet

Products

See Catalog

Know more about products

Contact

Contact Form

+33 2 38 49 45 73

Follow us

Other Infos

Legal notices

Privacy Policy & cookies infos

General terms & conditions

© Nucleosyn 2025 - All rights reserved

Design and development Think Ad Communication